Mitochondrial Dysfunction in Cardiac Diseases and Therapeutic Strategies.
Ontology highlight
ABSTRACT: Mitochondria are the main site of intracellular synthesis of ATP, which provides energy for various physiological activities of the cell. Cardiomyocytes have a high density of mitochondria and mitochondrial damage is present in a variety of cardiovascular diseases. In this paper, we describe mitochondrial damage in mitochondrial cardiomyopathy, congenital heart disease, coronary heart disease, myocardial ischemia-reperfusion injury, heart failure, and drug-induced cardiotoxicity, in the context of the key roles of mitochondria in cardiac development and homeostasis. Finally, we discuss the main current therapeutic strategies aimed at alleviating mitochondrial impairment-related cardiac dysfunction, including pharmacological strategies, gene therapy, mitochondrial replacement therapy, and m
SUBMITTER: Huang Y
PROVIDER: S-EPMC10216385 | biostudies-literature | 2023 May
REPOSITORIES: biostudies-literature
ACCESS DATA